rethinkTHC Search
Menu
Study breakdown

Medical Marijuana Access Did Not Reduce Post-Surgical Opioid Use in Teens and Young Adults

evidence
The takeaway

Medical marijuana dispensary laws were not associated with reduced prolonged opioid use after surgery in adolescents and young adults aged 12-25.

Pediatric surgeons, pain management specialists, and cannabis-opioid substitution researchers.

aOR 0.98 (not significant)

for medical marijuana dispensary law effect on prolonged opioid use in adolescents and young adults

What the researchers found

Medical marijuana dispensary laws showed no significant association with prolonged opioid use (aOR=0.98, 95% CI 0.81-1.18). Being female, longer hospital stays, greater initial opioid supply, and rural residence predicted prolonged use.

Why it matters

While cannabis access may reduce opioid use in adults, this large study suggests the same effect does not occur in the particularly vulnerable adolescent and young adult population.

The numbers in context

195,204 patients aged 12-25 across all 50 states (2005-2014). 4.8% had prolonged opioid use. Medical marijuana law: aOR=0.98 (not significant). Female: aOR=1.27. >14 days initial supply: aOR=2.42.

How the study worked

Retrospective cohort study using 2005-2014 MarketScan Commercial claims data for patients aged 12-25 undergoing 13 surgical procedures, with logistic regression for prolonged opioid use.

Who was studied

195,204 commercially insured adolescents and young adults (12-25) who underwent 13 surgical procedures across all 50 states.

What this study cannot tell us

Commercial insurance claims may not represent uninsured populations. Medical marijuana access does not equal use. 2005-2014 data predates recreational legalization in most states.

How to read the evidence

Large retrospective cohort with nationwide coverage; strong null finding for this age group.

When this study was published

Uses 2005-2014 claims data, before most recreational cannabis laws.

The bigger picture

The assumption that cannabis can substitute for opioids across all age groups is not supported for young people, highlighting the need for age-specific approaches to post-surgical pain management.

Replication

Pre-recreational legalization data; updated analysis warranted.

Funding

Not specified in abstract

Conflicts of interest

Not specified in abstract

Questions still open

  • Why might cannabis substitution for opioids work in adults but not young people?
  • Would more recent data including recreational legalization show different results?

Read the original research

Medical marijuana access and prolonged opioid use among adolescents and young adults.

The American journal on addictions, 32(5), 479-487

Citation

Kim, Kyungha; Pacula, Rosalie L; Dick, Andrew W; Stein, Bradley D; Druss, Benjamin G; Agbese, Edeanya; Cohrs, Austin C; Leslie, Douglas L. (2023). Medical marijuana access and prolonged opioid use among adolescents and young adults.. The American journal on addictions, 32(5), 479-487. https://doi.org/10.1111/ajad.13440